Pioglitazone recalls
Pioglitazone products have been recalled 2 times, most recently on 2 Feb 2022. The recalling company is usually Macleods Pharma Usa. The most common reason is potency & assay.
Total recalls2since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Feb 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why pioglitazone is recalled
Companies
Product types
By year
All pioglitazone recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Pioglitazone Tablets USP, 45 mg recalled by Aurobindo Pharma USAPioglitazone | Aurobindo Pharma USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Pioglitazone Hydrochloride Tablets USP 15 mg recalledPioglitazone | Macleods Pharma Usa | Potency & Assay | NJ |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.